Novel pyrazolo[3,4-d]pyrimidines as dual Src-Abl inhibitors active against mutant form of Abl and the leukemia K-562 cell line
- Citation:
- El-Moghazy, S. M., R. F. George, E. E. A. Osman, A. A. Elbatrawy, M. Kissova, A. Colombo, E. Crespan, and G. Maga, "Novel pyrazolo[3,4-d]pyrimidines as dual Src-Abl inhibitors active against mutant form of Abl and the leukemia K-562 cell line", European Journal of Medicinal Chemistry, vol. 123, pp. 1-13, 2016.